...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Re: Trial
1
Dec 10, 2019 03:57PM
1
Dec 10, 2019 09:20PM
3
Feb 09, 2020 10:02AM

My guess is this one:

American Association for Cancer Research 2020 meeting in San Diego end of April. https://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=213

5
Feb 13, 2020 02:57PM
Share
New Message
Please login to post a reply